X-group (possible homology)

3456 NADH-quinone oxidoreductase subunit A

Ligands and drugs

889
Member domains
279
with ligand contacts (≤ 4 Å)
31.4% of members
166
with DrugDomain annotations
18.7% of members
98
with a DrugBank compound
11.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

14
Proteins with classified ligands
3
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds06.80q = 4.0e-4
Hydrocarbons40.141×not tested
Lipids and lipid-like molecules141.59.11×not tested
Nucleosides, nucleotides, and analogues23.80.52×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB04327PEEPhosphatidylethanolamine62
DB03429CDLTetrastearoyl cardiolipin17
DB02338NDPNADPH6
DB07640DCQ2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione6
DB02043LHG1,2-Dipalmitoyl-Phosphatidyl-Glycerole4
DB02686UMQUndecyl-Beta-D-Maltopyranoside2
DB09270U10Ubidecarenone2
DB03426DGDDigalactosyl Diacyl Glycerol (Dgdg)1

Most frequently bound compounds

PDB ligandNameDomains in contact
3PE1,2-Distearoyl-sn-glycerophosphoethanolamine180
PC11,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE126
PEE1,2-dioleoyl-sn-glycero-3-phosphoethanolamine75
PLX(9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL71
CDLCARDIOLIPIN25
PLCDIUNDECYL PHOSPHATIDYL CHOLINE14
U10UBIQUINONE-107
PGT(1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE6
T7XPhosphatidylinositol6
DGDDIGALACTOSYL DIACYL GLYCEROL (DGDG)5
NDPNADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE5
UQ9Ubiquinone-95
LFAEICOSANE4
LHG1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE4
3PH1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE3
DU02-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol3
SQD1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL3
DCQ2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione2
PC7(7S)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE2
Q7G2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside2